SS

Sarika Sharma

Active Director Director DIN 03380480
DIN 03380480 First appointment Jan 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2007
Shareholding value •••• Premium profile

About Sarika Sharma

Data last updated:

Sarika Sharma is a Director at Upjone Lab Private Limited (since 2007). The company operates in Pharma. Upjone Lab Private Limited reported revenue of ₹1.09 Cr (FY 2024).

DIN 03380480
Primary Designation Director
Industry Pharma
First Appointment 11 Jan 2007
Oldest Company Age 19 yrs
Largest company Upjone Lab Private Limited · ₹1.09 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Upjone Lab Private Limited U33125MH2007PTC166895
Director11 Jan 20072007₹1.09 Cr (FY 2024)Active

Board colleagues of Sarika Sharma

NameDINCompanyDesignation
Yateendra Kumar Sharma00928874Upjone Lab Private LimitedDirector

Directorship timeline

Open interactive timeline →
Upjone Lab Private Limited
Premium access

Shareholding and investment profile for Sarika Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarika Sharma

Sarika Sharma currently holds 1 directorship: Upjone Lab Private Limited (Director, since 11 Jan 2007, revenue ₹1.09 Cr (FY 2024)).

Sarika Sharma was first appointed on 11 Jan 2007 as Director at Upjone Lab Private Limited.

The current boards of Sarika Sharma's companies include Yateendra Kumar Sharma (Upjone Lab Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available